TXN and cardiovascular disorder: Given the critical role of the thioredoxin system in these diseases, we speculate that TRXR1-specific inhibitors, by affecting the thioredoxin system and thus disulfide bonds, may also be applicable to cancer, cardiovascular diseases and CNS diseases.